Stati Uniti - Ingliż - NLM (National Library of Medicine)

sanofi-aventis u.s. llc - insulin lispro (unii: gfx7qis1ii) (insulin lispro - unii:gfx7qis1ii) - insulin lispro 100 u in 1 ml - admelog is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. admelog is contraindicated: - during episodes of hypoglycemia [see warnings and precautions (5.3)] . - in patients who are hypersensitive to insulin lispro or to any of the excipients in admelog [see warnings and precautions (5.5)]. risk summary published studies with another insulin lispro product used during pregnancy have not reported an association between insulin lispro and the induction of major birth defects, miscarriage, or adverse maternal or fetal outcomes [see data] . there are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy [see clinical considerations] . pregnant rats and rabbits were exposed to another insulin lispro product in animal reproduction studies during organogenesis. fetal growth retardation was observed in offspring of rats exposed to insulin lispro at a dose approximately 3 times the human subcutaneous dose of 1.0 unit/kg/day. no adverse effe

Stati Uniti - Ingliż - NLM (National Library of Medicine)

remedyrepack inc. - insulin lispro (unii: gfx7qis1ii) (insulin lispro - unii:gfx7qis1ii) - admelog is indicated to improve glycemic control in adults and pediatric patients 3 years and older with type 1 diabetes mellitus and adults with type 2 diabetes mellitus. admelog is contraindicated: - during episodes of hypoglycemia. - in patients who are hypersensitive to insulin lispro or to any of the excipients. risk summary the limited available data with admelog in pregnant women are insufficient to inform a drug-associated risk of adverse developmental outcomes. published studies with another insulin lispro product used during pregnancy have not reported an association between insulin lispro and the induction of major birth defects, miscarriage, or adverse maternal or fetal outcomes [see data] . there are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy [see clinical considerations] . pregnant rats and rabbits were exposed to another insulin lispro product i

Filippini - Ingliż - FDA (Food And Drug Administration)

20160808153621 - pt sanghiang perkasa -

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

ikaria australia pty ltd - methoxsalen, quantity: 0.2 mg - injection, concentrated - excipient ingredients: ethanol; glacial acetic acid; propylene glycol; sodium acetate trihydrate; sodium chloride; water for injections; sodium hydroxide - uvadex (methoxsalen) is indicated for extracorporeal administration with the therakos cellex photopheresis system for the: ? treatment of steroid-refractory and steroid-intolerant chronic graft versus host disease (cgvhd) in adults following allogeneic hsc transplantation. ? palliative treatment of the skin manifestations of cutaneous t-cell lymphoma (ctcl) that is unresponsive to other forms of treatment.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

l'oreal usa products inc - octinoxate 4%, titanium dioxide 3.6% - sunscreen - helps prevent sunburn - if used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun on damaged or broken skin

Stati Uniti - Ingliż - NLM (National Library of Medicine)

l'oreal usa products inc - avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm) - avobenzone 30 mg in 1 ml - sunscreen - helps prevent sunburn - if used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun on damaged or broken skin rash occurs

Stati Uniti - Ingliż - NLM (National Library of Medicine)

l’oreal usa products inc - avobenzone 3%, homosalate 10.72%, octisalate 3.21%, octocrylene 6%, oxybenzone 3.86% - sunscreen - helps prevent sunburn - if used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun on damaged or broken skin rash occurs

Stati Uniti - Ingliż - NLM (National Library of Medicine)

l'oreal usa products inc - avobenzone 3%, octisalate 5%, octocrylene 7% - sunscreen - helps prevent sunburn - if used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun on damaged or broken skin rash occurs

Stati Uniti - Ingliż - NLM (National Library of Medicine)

l'oreal usa products inc - avobenzone 3%, octisalate 5%, octocrylene 7% - sunscreen - helps prevent sunburn - if used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun on damaged or broken skin rash occurs

Stati Uniti - Ingliż - NLM (National Library of Medicine)

l'oreal usa products inc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 20 mg in 1 ml - acne treatment for the treatment of acne